TY - JOUR T1 - Specifically Targeting Interleukin-13 with Tralokinumab Improved Sleep in Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Trials in Patients with Atopic Dermatitis JO - SKIN The Journal of Cutaneous Medicine PY - 2021/01/01 AU - Silverberg J AU - Barbarot S AU - Gooderham M AU - Simon J AU - Simpson E AU - Kurbasic A AU - Olsen C AU - Cork M ED - DO - DOI: 10.25251/skin.5.supp.9 PB - National Society for Cutaneous Medicine VL - 5 IS - 1 SP - s9 EP - s9 Y2 - 2025/08/13 ER -